Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Colorectal Neoplasms

Free Subscription Articles published in BMC Cancer Retrieve available abstracts of 361 articles: HTML format

Single Articles

July 2026
1. FAGHIR-GANJI M, Abdolmohamadi N, Ansari-Moghaddam A, Eshrati B, et al
   Abdominal obesity and colorectal cancer risk: a systematic review and updated meta-analysis.
   BMC Cancer. 2026 Jul 21. doi: 10.1186/s12885-026-16351.
   PubMed     Abstract available
   
   
   
2. CHEN H, Jiang T, Wang H, Zheng J, et al
   Efficacy and safety of cetuximab-irinotecan rechallenge versus regorafenib in ras wild-type metastatic colorectal cancer: a single-center exploratory randomized trial.
   BMC Cancer. 2026 Jul 21. doi: 10.1186/s12885-026-16491.
   PubMed     Abstract available
   
   
   
3. LIU B, Zheng X, Li J, Yao P, et al
   Retraction Note: Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRbeta/NF-kappaB signaling pathway.
   BMC Cancer. 2026;26:869.
   PubMed    
   
   
   
4. TAO D, He H, Chen J, Li X, et al
   Preoperative tumor marker burden score predicts survival in colorectal cancer according to tumor size.
   BMC Cancer. 2026 Jul 16. doi: 10.1186/s12885-026-16563.
   PubMed     Abstract available
   
   
   
5. LIU Y, He JT, Lin GH, Fu C, et al
   Treatment outcomes of fruquintinib combined with PD-1 inhibitors in advanced colorectal cancer: a reconstructed patient-level meta-analysis of retrospective real-world studies.
   BMC Cancer. 2026 Jul 15. doi: 10.1186/s12885-026-16420.
   PubMed     Abstract available
   
   
   
6. YANG K, Li H, Dong X, Lin J, et al
   Combining tertiary lymphoid structures and tumor stroma percentage for predicting prognosis and chemotherapy benefits in stage II-III colorectal cancer.
   BMC Cancer. 2026 Jul 14. doi: 10.1186/s12885-026-16542.
   PubMed     Abstract available
   
   
   
7. YANG L, Han Y, Ji J, Wang Y, et al
   Uncovering the mechanism of DCLK3 in colorectal cancer progression through WGCNA and machine learning.
   BMC Cancer. 2026 Jul 10. doi: 10.1186/s12885-026-16479.
   PubMed     Abstract available
   
   
   
8. BAO Z, Gao J, Cheng X, Yang W, et al
   Ethyl caffeate reprograms tumor-associated macrophages to enhance CD8(+) T-cell immunity in colorectal cancer.
   BMC Cancer. 2026 Jul 6. doi: 10.1186/s12885-026-16469.
   PubMed     Abstract available
   
   
   
9. DE CASTRO E GLORIA H, Nogueira LJ, Grudzinski PB, da Costa Ghignatti PV, et al
   Correction: Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells.
   BMC Cancer. 2026;26:795.
   PubMed    
   
   
   June 2026
10. GIEHL-BROWN E, Nikbakhsh R, Mansourkiaei A, Jotten L, et al
    Delaying surgery beyond six weeks after systemic therapy reduces postoperative morbidity without evidence of impaired oncologic outcomes in colorectal liver metastases.
    BMC Cancer. 2026;26:786.
    PubMed     Abstract available
    
    
    
11. WU W, Cheng C, Yang T, Meng W, et al
    NT5E promotes colorectal cancer progression and correlates with PD-L1 expression: evidence from multi-omics analysis, clinical samples, and cellular functional assays.
    BMC Cancer. 2026 Jun 30. doi: 10.1186/s12885-026-16395.
    PubMed     Abstract available
    
    
    
12. ALIZADEH F, Rajabi A, Goharmomayez S, Fathi M, et al
    Doxorubicin-loaded chitosan/gold nanoparticles enhance anticancer effects and reduce CLMAT3 and ZNRD1-AS1 expression in colorectal cancer cells.
    BMC Cancer. 2026 Jun 27. doi: 10.1186/s12885-026-16385.
    PubMed     Abstract available
    
    
    
13. LI Z, Cao J, Chen S, Chai G, et al
    Factors associated with quality of work life among colorectal cancer survivors: a cross-sectional study after returning to work.
    BMC Cancer. 2026 Jun 22. doi: 10.1186/s12885-026-16400.
    PubMed     Abstract available
    
    
    
14. ZHANG Z, Ouyang P, Cui K, Lai J, et al
    Dissecting T-cell exhaustion heterogeneity and immune ecosystem dynamics in colorectal cancer through multi-omics machine learning.
    BMC Cancer. 2026 Jun 19. doi: 10.1186/s12885-026-16343.
    PubMed     Abstract available
    
    
    
15. LIN YT, Chang AC, Chien CS, Lin CC, et al
    Circulating N6-methyladenosine RNA as a diagnostic and a stage-associated prognostic biomarker in colorectal cancer.
    BMC Cancer. 2026 Jun 15. doi: 10.1186/s12885-026-16290.
    PubMed     Abstract available
    
    
    
16. LE KT, Tran HD, Do MD, Nguyen TH, et al
    Clinical factors are more strongly associated with prognosis than genetic alterations in early-onset colorectal cancer: a retrospective cohort study.
    BMC Cancer. 2026 Jun 11. doi: 10.1186/s12885-026-16331.
    PubMed     Abstract available
    
    
    
17. MEHRJOEI B, Tahmasebi S, Haghnazari L, Rezvani P, et al
    Upregulation of miR-32 in tissue and plasma and its association with PTEN expression in colorectal cancer.
    BMC Cancer. 2026 Jun 8. doi: 10.1186/s12885-026-16214.
    PubMed     Abstract available
    
    
    
18. HUANG Y, Acuna-Villaorduna A, Gali R, Maia C, et al
    The prognostic significance of B7-H3 expression in patients with advanced colorectal cancer.
    BMC Cancer. 2026 Jun 5. doi: 10.1186/s12885-026-16300.
    PubMed     Abstract available
    
    
    May 2026
19. FAN W, Ma X
    Acetyltransferase NAT10 promotes aggressiveness of colorectal cancer cells via ac(4)C acetylation of SERPINA1 mRNA.
    BMC Cancer. 2026 May 30. doi: 10.1186/s12885-026-16215.
    PubMed     Abstract available
    
    
    
20. PAN Y, Xiang X, Li J, Ge Y, et al
    Single-cell transcriptome analysis reveals SOX9 mutation-driven tumor stemness and microenvironment remodeling through the COL1A1-CD44 axis in colorectal cancer.
    BMC Cancer. 2026 May 30. doi: 10.1186/s12885-026-16248.
    PubMed     Abstract available
    
    
    
21. WANG Y, Jing Y, Yang Y, Zhang B, et al
    Clinicopathological, prognostic, and molecular differences between microsatellite-stable colorectal cancer patients aged 30 years.
    BMC Cancer. 2026 May 29. doi: 10.1186/s12885-026-16262.
    PubMed     Abstract available
    
    
    
22. MARTIN-SANCHEZ C, Polo-Ferrero L, Mendez-Sanchez R, Puente-Gonzalez AS, et al
    8- versus 12-week supervised resistance training with home-based physical activity during colorectal cancer treatment: a pilot randomized dose-comparison trial.
    BMC Cancer. 2026 May 28. doi: 10.1186/s12885-026-16245.
    PubMed     Abstract available
    
    
    
23. HONG Z, Chen S, Zhang C, Yu J, et al
    Impact of mucinous histology on the efficacy of neoadjuvant immunotherapy in localized mismatch repair-deficient colorectal cancer.
    BMC Cancer. 2026 May 27. doi: 10.1186/s12885-026-16231.
    PubMed     Abstract available
    
    
    
24. ZHANG LJ, Zhang CY, Li MX, Zhang D, et al
    Prognostic role of HSPs in human colorectal cancer: a systematic review and meta-analysis.
    BMC Cancer. 2026 May 23. doi: 10.1186/s12885-026-16125.
    PubMed     Abstract available
    
    
    
25. LIN L, Chen Z, Zhang CY, Fang J, et al
    Role of glutathione disulfide reductase in colorectal cancer: a tumor suppressor.
    BMC Cancer. 2026 May 22. doi: 10.1186/s12885-026-16174.
    PubMed     Abstract available
    
    
    
26. KEEL B, Quyn A, Jayne D, Relton SD, et al
    Radiological staging clinical decision support model for rectal cancer lymph node metastasis detection on MRI.
    BMC Cancer. 2026;26:828.
    PubMed     Abstract available
    
    
    
27. WANG S, Gu R, Lu J, Wang S, et al
    Efficacy and risk analysis of monotherapy and dual immunotherapy in dMMR/MSI-H metastatic colorectal cancer: a meta-analysis based on randomized controlled trials.
    BMC Cancer. 2026;26:663.
    PubMed     Abstract available
    
    
    
28. SAOUB S, Metzen E, Thakur BK, Henning Y, et al
    P53 - a new player in the metabolic adaptation of colorectal carcinoma cells under hypoxia.
    BMC Cancer. 2026;26:628.
    PubMed     Abstract available
    
    
    
29. BANKEN E, Borg M, van Hellemond IEG, van Ravensteijn SG, et al
    A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: st
    BMC Cancer. 2026;26:838.
    PubMed     Abstract available
    
    
    
30. TER KUILE EM, Kok N, Westerink B, Swijnenburg RJ, et al
    Hepatic arterial infusion pump chemotherapy combined with systemic therapy versus systemic therapy alone as induction treatment for initially unresectable colorectal liver metastases: a study protocol of the randomised controlled trial - PUMP-IT RCT.
    BMC Cancer. 2026 May 16. doi: 10.1186/s12885-026-16130.
    PubMed     Abstract available
    
    
    
31. VIRDEE PS, Birks J, Holt T, Snell KIE, et al
    Full BLOOD count TRends for colorectal cAnCer deteCtion (BLOODTRACC): external validation of dynamic clinical prediction models for early detection of colorectal cancer in primary care.
    BMC Cancer. 2026 May 14. doi: 10.1186/s12885-026-16179.
    PubMed     Abstract available
    
    
    
32. WANG L, Yue Q, Li KQ, Fu DH, et al
    Associations of oral health with colorectal cancer risk: accumulated evidences from observational studies.
    BMC Cancer. 2026 May 13. doi: 10.1186/s12885-026-16158.
    PubMed     Abstract available
    
    
    
33. WANG J, Zhang J, Wu Z, Zhao Y, et al
    Smoking metabolic signature modifies the risk of colorectal cancer and interacts with genetic susceptibility: a large-scale prospective cohort study.
    BMC Cancer. 2026 May 8. doi: 10.1186/s12885-026-16123.
    PubMed     Abstract available
    
    
    
34. CAO M, Hao J, Jiang L
    SPINK4 affected M2 macrophage polarization to promote colorectal cancer malignant phenotype by PI3K/AKT pathway.
    BMC Cancer. 2026 May 7. doi: 10.1186/s12885-026-16126.
    PubMed     Abstract available
    
    
    
35. WANG LJ, Liu XY, Tan C, Wang ZW, et al
    The impact of advanced glycation end products and their receptors on the development and prognosis of colorectal cancer.
    BMC Cancer. 2026 May 6. doi: 10.1186/s12885-026-16070.
    PubMed     Abstract available
    
    
    April 2026
36. LEE S, Yu J, Kampalath R, Castillo O, et al
    Computed tomography staging of colon cancer: improved patient selection for neoadjuvant therapy with combined radiologic tumor and nodal staging.
    BMC Cancer. 2026 Apr 28. doi: 10.1186/s12885-026-16056.
    PubMed    
    
    
    
37. BORG M, Farver-Vestergaard I, Hilberg O, Steed L, et al
    Long-term risk of depression in lung, colon, breast, and prostate cancer: a 25-year nationwide comparative study.
    BMC Cancer. 2026 Apr 28. doi: 10.1186/s12885-026-16095.
    PubMed    
    
    
    
38. OSTERMAN E, Syriopoulou E, Martling A, Andersson TM, et al
    Risk of colorectal cancer by socioeconomic position and history of mental illness - a national nested case-control study.
    BMC Cancer. 2026;26:527.
    PubMed     Abstract available
    
    
    
39. YANG M, Yang S, Zhang W, Ma F, et al
    Propensity score-matched evaluation of prophylactic hyperthermic intraperitoneal chemotherapy in geriatric patients with locally advanced colorectal cancer: safety and survival benefits.
    BMC Cancer. 2026 Apr 25. doi: 10.1186/s12885-026-16073.
    PubMed    
    
    
    
40. THET D, Areepium N, Rungruang C, Leelakanok N, et al
    Circulating vitamin D status and prognosis in colorectal cancer: a systematic review and meta-analysis with exploratory evidence on vitamin D receptor polymorphisms.
    BMC Cancer. 2026 Apr 16. doi: 10.1186/s12885-026-16026.
    PubMed    
    
    
    
41. MOSTAFAVI-FINI HS, Moradi A, Gowdini E, Mohammadi R, et al
    Aspirin alters molecular crosstalk between prostaglandin, apoptosis, and invasion pathways in colorectal cancer.
    BMC Cancer. 2026 Apr 14. doi: 10.1186/s12885-026-15872.
    PubMed    
    
    
    
42. LI Q, Chen Q, Chang J, Fu T, et al
    Metabolomics and proteomics analyses reveal the potiental mechanisms underlying colorectal cancer and chemotherapy targets.
    BMC Cancer. 2026 Apr 11. doi: 10.1186/s12885-026-15978.
    PubMed    
    
    
    
43. XI X, Zhang B
    RGD-modified hollow mesoporous nanoparticles loaded with cisplatin for antitumor therapy in colon cancer.
    BMC Cancer. 2026 Apr 11. doi: 10.1186/s12885-026-15923.
    PubMed    
    
    
    
44. PURBA CIH, Anggraeni R, Pahria T
    Exploration of patients and multidisciplinary point of view about the self-care needs of patients with a stoma: a qualitative study.
    BMC Cancer. 2026;26:647.
    PubMed     Abstract available
    
    
    
45. HUANG YJ, Lee HH, Chen WM, Peng SM, et al
    Dose-response effect of statins on colorectal cancer risk in IBD: a nationwide cohort study.
    BMC Cancer. 2026 Apr 10. doi: 10.1186/s12885-026-15970.
    PubMed    
    
    
    
46. DU Z, Li DZ, Xu ZL, Li Q, et al
    Identification and verification of an eight-gene prognostic signature for colorectal cancer based on tumor-associated macrophages.
    BMC Cancer. 2026 Apr 6. doi: 10.1186/s12885-026-15965.
    PubMed    
    
    
    
47. WANG Z, Cao Y, Wang Q, Wang L, et al
    Real-world evidence for first-line intrathecal pemetrexed in leptomeningeal metastases from solid tumors: a retrospective cohort study.
    BMC Cancer. 2026;26:651.
    PubMed     Abstract available
    
    
    March 2026
48. HASHEMI F, Dehghan Manshadi M, Safaei S, Aminianfar H, et al
    Therapeutic efficacy of cancer stem cell-based vaccine in colorectal murine model: reduced tumor growth and prolonged survival.
    BMC Cancer. 2026 Mar 29. doi: 10.1186/s12885-026-15925.
    PubMed    
    
    
    
49. MATBOLI M, Elanwar A, Ibrahim W, Hassan MK, et al
    Role of SFTPD/miR-335-5p/lnc-HNRNPUL2 axis in colorectal cancer: in silico characterization and clinical validation.
    BMC Cancer. 2026 Mar 26. doi: 10.1186/s12885-026-15833.
    PubMed    
    
    
    
50. SCHOTTKER B, Kopp-Schneider A, Biehl L
    Protocol of the LEONORA randomized clinical trial: Lower gastrointestinal symptom burden by prophylaxis with synbiotics after colorectal cancer surgery.
    BMC Cancer. 2026 Mar 25. doi: 10.1186/s12885-026-15903.
    PubMed    
    
    
    
51. MO H, Zhang W, Wei J, Chen J, et al
    Comparison of clinical, pathological and genomic characteristics between Lynch and non-Lynch patients with MMRd endometrial carcinoma.
    BMC Cancer. 2026 Mar 24. doi: 10.1186/s12885-026-15826.
    PubMed    
    
    
    
52. SIEGEL R, Dittrich L, Plewe J, Denecke T, et al
    PROTECTOR / FIRE?10: study protocol for a prospective, randomized, open-label, multicenter phase III trial to investigate the efficacy of preoperative systemic therapy in advanced colon cancer.
    BMC Cancer. 2026 Mar 20. doi: 10.1186/s12885-026-15682.
    PubMed    
    
    
    
53. AN B, Wang J, Li Z, Peng L, et al
    Integrating network pharmacology and experimental validation to elucidate the mechanism by which 2-Dihydroailanthone induces HCT116 cell death through suppressing autophagy via the AMPK/mTOR pathway.
    BMC Cancer. 2026;26:521.
    PubMed     Abstract available
    
    
    
54. HOU S, Wu X, Zhu H, Yao Y, et al
    The prognostic value of immunoscore in colorectal cancer liver metastases: a meta-analysis reveals the superiority of metastatic over primary tumor profiling.
    BMC Cancer. 2026 Mar 14. doi: 10.1186/s12885-026-15867.
    PubMed    
    
    
    
55. GAO X, Zhang H, Wang Y, Hu P, et al
    Network pharmacology and molecular docking analysis on mechanisms of Euphorbia Lathyris L. seed in treating colorectal cancer.
    BMC Cancer. 2026 Mar 11. doi: 10.1186/s12885-026-15778.
    PubMed    
    
    
    
56. ZHAO F, Lin H, Han R, Wang M, et al
    Genetic landscape of Chinese colorectal cancer: insights into germline and somatic mutations.
    BMC Cancer. 2026 Mar 10. doi: 10.1186/s12885-026-15626.
    PubMed    
    
    
    
57. O'CONNELL LV, Murnaghan N, O'Brien A, Shields C, et al
    Significance of nodal yield after rectal resection in the TNT era: does count matter?
    BMC Cancer. 2026;26:446.
    PubMed     Abstract available
    
    
    February 2026
58. HUANG M, Qin Y, Yang Q, Chen X, et al
    UHRF2 related to sumoylation : assessment of its role in immune suppression and therapeutic potential in colorectal cancer.
    BMC Cancer. 2026 Feb 27. doi: 10.1186/s12885-026-15727.
    PubMed     Abstract available
    
    
    
59. SAHM SW, Neumann UP, Zahn MO, Schwittay M, et al
    ERBITAG: Non-interventional study on the efficacy of cetuximab in first-line therapy in patients with RAS wild-type metastatic colorectal cancer.
    BMC Cancer. 2026 Feb 25. doi: 10.1186/s12885-026-15753.
    PubMed    
    
    
    
60. ZHU H, Cai Y, Ke C, Wang H, et al
    Clinical risk factors and survival analysis of postoperative recurrence or metastasis of colorectal cancer.
    BMC Cancer. 2026 Feb 24. doi: 10.1186/s12885-026-15779.
    PubMed     Abstract available
    
    
    
61. GONJOBE MS, Dharsee N, Mduma E, Maunda KK, et al
    Oxaliplatin induced peripheral neuropathy and associated factors among colorectal cancer patients in Tanzania.
    BMC Cancer. 2026 Feb 18. doi: 10.1186/s12885-026-15769.
    PubMed     Abstract available
    
    
    
62. XIA W, Luo Z, Shan S, Chen J, et al
    Chemotherapy-related symptoms in colorectal cancer patients: A latent profile analysis.
    BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15710.
    PubMed    
    
    
    
63. ZHAO Q, Zhao K, Song J, Zhao W, et al
    Immune checkpoint inhibitor in third-line treatment of microsatellite stable metastatic colorectal cancer: an observational and retrospective study.
    BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15740.
    PubMed    
    
    
    
64. LIU Q, Jiao HY, Wang YY, Zhu LL, et al
    The tumor-suppressive function of the unique H domain of FCGBP and its potential as a therapeutic target in colorectal cancer.
    BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15718.
    PubMed    
    
    
    
65. MARTINEZ-LAGO N, Carnero Lopez B, de la Camara Gomez JC, Vazquez Rivera F, et al
    Comparative prognostic performance of the REBECCA score and the Tabernero classification in refractory metastatic colorectal cancer treated with regorafenib: a multicenter real-world study.
    BMC Cancer. 2026 Feb 15. doi: 10.1186/s12885-026-15745.
    PubMed    
    
    
    
66. XU H, Yan Y, Niu J, Cao L, et al
    Surufatinib plus tislelizumab as later-line therapy for metastatic colorectal cancer: a single-arm, phase II trial.
    BMC Cancer. 2026 Feb 11. doi: 10.1186/s12885-026-15705.
    PubMed    
    
    
    
67. ERDOGAN ASO, Shu Y, Gootjes E, Simmer F, et al
    Patients with tumor deposits benefit equally from adjuvant therapy compared to other stage III colon cancer groups: two retrospective population-based studies.
    BMC Cancer. 2026 Feb 6. doi: 10.1186/s12885-026-15668.
    PubMed    
    
    
    
68. WU ZJ, Gong H, Li YX, Li Y, et al
    Missed anal and anorectal tumors during endoscopic examinations: a ten-year retrospective study.
    BMC Cancer. 2026;26:353.
    PubMed     Abstract available
    
    
    
69. WANG Q, Wang YK, Zhang P, Liu WK, et al
    Comprehensive bioinformatics analysis and clinical validation of PPP1R13L in rectal adenocarcinoma.
    BMC Cancer. 2026;26:584.
    PubMed     Abstract available
    
    
    
70. TRAN CG, Dornbush C, Jensen BS, Mott SL, et al
    Obesity, survival, and chemotherapy outcomes in stage IV colorectal cancer: a retrospective study.
    BMC Cancer. 2026 Feb 5. doi: 10.1186/s12885-026-15653.
    PubMed    
    
    
    
71. XIE H, Chen T, Lan B, Zhou Q, et al
    The prognostic value of preoperative Naples prognostic score for overall survival and progression-free survival in colorectal cancer.
    BMC Cancer. 2026 Feb 3. doi: 10.1186/s12885-026-15679.
    PubMed    
    
    
    January 2026
72. YU Y, Jiang X, Pei B, Zhou J, et al
    Proteome profiling reveals early diagnostic biomarker candidates for colorectal cancer.
    BMC Cancer. 2026 Jan 28. doi: 10.1186/s12885-026-15547.
    PubMed     Abstract available
    
    
    
73. XU T, Shi J, Ma H, Shuai J, et al
    Long-term outcomes and anorectal functional status of patients with anal squamous cell carcinoma treated with the modern technique of intensity-modulated radiotherapy.
    BMC Cancer. 2026;26:286.
    PubMed     Abstract available
    
    
    
74. LIU D, Fan Z, Zhang T, Li X, et al
    Rs12516 A allele elevates the risk of colorectal cancer via functional CeRNA network of BDNF-AS, miR-4704-5p and BRCA1.
    BMC Cancer. 2026 Jan 19. doi: 10.1186/s12885-025-14692.
    PubMed     Abstract available
    
    
    
75. SUN H, Hu N, Ma S, Zheng Y, et al
    T-cell exhaustion indicator characterizes the tumor microenvironment landscape and predicts colon adenocarcinoma prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing.
    BMC Cancer. 2026;26:215.
    PubMed     Abstract available
    
    
    
76. PANG H, Dai F, Zhao Z, Chen X, et al
    Clinical significance of the pretreatment C-reactive protein-albumin-lymphocyte (CALLY) index in colorectal cancer patients: a meta-analysis.
    BMC Cancer. 2026 Jan 13. doi: 10.1186/s12885-026-15557.
    PubMed    
    
    
    
77. SUN Z, Tan P, Zhou S, Ma W, et al
    Comprehensive pan-cancer analysis and experimental verification of the roles of SCP2 in colon adenocarcinoma.
    BMC Cancer. 2026;26:208.
    PubMed     Abstract available
    
    
    
78. LIN J, Ling Z, Fan W, Cai Q, et al
    Establishment of a microbial abundance prognostic model for colorectal cancer.
    BMC Cancer. 2026 Jan 10. doi: 10.1186/s12885-025-15524.
    PubMed    
    
    
    
79. ADAMSON B, van Boemmel-Wegmann S, Horne E, Soares S, et al
    Real-world evidence from Germany: representativeness analysis and mortality endpoint validation in electronic health record-derived oncology cohorts.
    BMC Cancer. 2026;26:202.
    PubMed     Abstract available
    
    
    
80. KASSAW AB, Abera MB, Seid MA, Jemal M, et al
    KRAS mutation and its association with clinicopathological features of colorectal cancer patients in Africa: a systematic review and meta-analysis.
    BMC Cancer. 2026;26:31.
    PubMed     Abstract available
    
    
    
81. FAN S, Shao M, Ma W
    Association between serum uric acid levels and clinical outcomes of immunotherapy in advanced colorectal cancer patients.
    BMC Cancer. 2026 Jan 3. doi: 10.1186/s12885-025-15431.
    PubMed     Abstract available
    
    
    December 2025
82. LI G, Qiu X, Xu L, Lu J, et al
    Clinical characteristics and survival outcomes of well-responders following definite comprehensive treatment in locally advanced rectal cancer.
    BMC Cancer. 2025;26:293.
    PubMed     Abstract available
    
    
    
83. NADERI NOUKABADI F, Daskar Abkenar E, Tierling S, Shojaee S, et al
    Circulating protein levels of insulin-like growth factor 1 signaling pathway and the predisposition to colorectal carcinogenesis: a systematic review and meta-analysis.
    BMC Cancer. 2025;26:218.
    PubMed     Abstract available
    
    
    
84. HUO J, Chen H, Zhang X, Sun D, et al
    Histone acetyltransferase KAT6A contributes to colon cancer malignant progression by inhibiting ferroptosis.
    BMC Cancer. 2025 Dec 27. doi: 10.1186/s12885-025-15368.
    PubMed     Abstract available
    
    
    
85. MAHJOURIAN MM, Zeinalabedini M, Hanjani NA, Azadbakht L, et al
    Association of dietary carbohydrate intake, glycemic index, and glycemic load with colorectal cancer risk in adults: a systematic review and dose-response meta-analysis of prospective cohort studies.
    BMC Cancer. 2025 Dec 27. doi: 10.1186/s12885-025-15466.
    PubMed    
    
    
    
86. LI G, Wang D, Chen G
    Single-cell RNA sequencing defines prognostic subtypes and identifies AIF1L as a therapeutic target in colorectal cancer.
    BMC Cancer. 2025;25:1885.
    PubMed     Abstract available
    
    
    
87. WANG D, Zhao Z, Zhao W, Chen G, et al
    Surgery versus stereotactic body radiotherapy for oligometastatic colorectal cancer: a prospective cohort study with propensity score matching.
    BMC Cancer. 2025 Dec 22. doi: 10.1186/s12885-025-15448.
    PubMed     Abstract available
    
    
    
88. HU F, Shi X, Cheng X, Yao H, et al
    Methylmalonic acid modulates neutrophil function to promote tumor progression in colorectal cancer.
    BMC Cancer. 2025 Dec 22. doi: 10.1186/s12885-025-15489.
    PubMed    
    
    
    
89. HARRISON TA, Zaidi SH, Yin H, Steinfelder RS, et al
    Genomic characterization of colorectal tumors: insights into significantly mutated genes, pathways, and survival outcomes.
    BMC Cancer. 2025;26:109.
    PubMed     Abstract available
    
    
    
90. YI Y, Cao Y, Guo Y, Cui Y, et al
    Serum untargeted metabolomics analysis of colorectal cancer.
    BMC Cancer. 2025 Dec 15. doi: 10.1186/s12885-025-15433.
    PubMed     Abstract available
    
    
    
91. ZHANG Y, Zhang W, Li T, Hao E, et al
    A Multi-PTM omics atlas uncovers novel aging regulators in colorectal cancer.
    BMC Cancer. 2025 Dec 12. doi: 10.1186/s12885-025-15274.
    PubMed     Abstract available
    
    
    
92. AZARSHIN SZ, Malmir M, Sajjadi SF, Behmanesh M, et al
    CXCR3 gene as a therapeutic target in colorectal cancer.
    BMC Cancer. 2025 Dec 12. doi: 10.1186/s12885-025-15409.
    PubMed     Abstract available
    
    
    November 2025
93. PAN Y, Ying H, Luo M, Xuan Q, et al
    The co-location of MARCO + macrophages and SPOCK1 + fibroblasts contributes to the poor prognosis and undesirable immunotherapy response in colorectal cancer.
    BMC Cancer. 2025 Nov 28. doi: 10.1186/s12885-025-15397.
    PubMed    
    
    
    
94. YANG Q, Hu Y, Liu F
    Secular trend of colorectal cancer related with low physical activity from 1990 to 2021 in China.
    BMC Cancer. 2025 Nov 26. doi: 10.1186/s12885-025-15290.
    PubMed     Abstract available
    
    
    
95. XIE HB, Zhang BB, Zhao L, Liu L, et al
    Prealbumin predicts metachronous liver metastasis in colorectal cancer.
    BMC Cancer. 2025 Nov 25. doi: 10.1186/s12885-025-15296.
    PubMed     Abstract available
    
    
    
96. LI K, Zhang R, Zhang J, Zhang Z, et al
    The prognostic role of inflammation-based hematologic markers in stage I-III colorectal cancer: a retrospective analysis.
    BMC Cancer. 2025;25:1822.
    PubMed     Abstract available
    
    
    
97. JIN X, Bai B, Pan Y, Xie S, et al
    Distinct clinical features and epidemiological trends of very early and middle-aged early onset colorectal cancer based on SEER 17 and GBD 2021 data over the past 15 years.
    BMC Cancer. 2025 Nov 22. doi: 10.1186/s12885-025-15263.
    PubMed     Abstract available
    
    
    
98. PASSARDI A, Sullo FG, Bittoni A, Matteucci L, et al
    CombiCoR-Vax trial: study protocol for a phase II, single-arm, multicenter trial of sequential pembrolizumab plus dendritic cell vaccine followed by trifluridine/tipiracil and bevacizumab in refractory microsatellite-stable metastatic colorectal cance
    BMC Cancer. 2025 Nov 22. doi: 10.1186/s12885-025-15371.
    PubMed     Abstract available
    
    
    
99. WANG L, Wu H, Chen Y, Wang G, et al
    Single-cell RNA sequencing reveals neutrophil differentiation-related genes for immunotherapy response prediction in colorectal cancer.
    BMC Cancer. 2025 Nov 22. doi: 10.1186/s12885-025-15355.
    PubMed    
    
    
    
100. SALGADO M, de la Camara-Gomez J, Garcia-Escobar I, Alvarez-Llosa RC, et al
     Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design.
     BMC Cancer. 2025;25:1773.
     PubMed     Abstract available
     
     
     
101. MANSFIELD ME, Volpi CR, John C, Adebiyi R, et al
     Facilitator and barrier perspectives on learning and implementing high-resolution anoscopy in Abuja, Nigeria: a qualitative study.
     BMC Cancer. 2025;25:1766.
     PubMed     Abstract available
     
     
     
102. WU S, Zhang Y, Lin Z, Wei M, et al
     Global burden of colorectal cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN.
     BMC Cancer. 2025;25:1770.
     PubMed     Abstract available
     
     
     
103. FAN Y, Yang R, Shu Y, Xie W, et al
     Preoperative prediction and localization of synchronous metastases in colon cancer: the role of CECT combined with clinical characteristics.
     BMC Cancer. 2025;25:1755.
     PubMed     Abstract available
     
     
     
104. ZHANG C, Zhang F, Hong H, Qu Y, et al
     Efficacy and safety of neoadjuvant chemoradiotherapy versus chemotherapy alone in locally advanced rectal cancer.
     BMC Cancer. 2025;25:1749.
     PubMed     Abstract available
     
     
     
105. NARAYANAN MP, Sehrawat A, Goyal B, Kumar P, et al
     Association between insulin resistance biomarkers and metastatic prognosis in treatment-naive colorectal cancer patients: a pilot study.
     BMC Cancer. 2025;25:1711.
     PubMed    
     
     
     
106. GU W, Li H
     Prognostic value of controlling nutritional status score (CONUT) in patients with colorectal cancer: a systematic review and meta-analysis.
     BMC Cancer. 2025;25:1721.
     PubMed     Abstract available
     
     
     
107. HUANG H, Wang L, Gao S, Wang H, et al
     COMP promotes the progression of colorectal cancer by regulating epithelial mesenchymal transition.
     BMC Cancer. 2025;25:1710.
     PubMed    
     
     
     
108. FENG Q, Ni C, Zhou F, Zhu J, et al
     Clinical relevance of perioperative changes in circulating tumor cells in resectable colorectal cancer.
     BMC Cancer. 2025;25:1689.
     PubMed     Abstract available
     
     
     October 2025
109. WEI H, Yuan L, Li Y, Xia Y, et al
     Global status and attributable risk factors of esophageal, stomach, colorectal cancers in adolescents and young adults: global burden of disease 2021 study analysis.
     BMC Cancer. 2025;25:1682.
     PubMed     Abstract available
     
     
     
110. PRADHAN P, Chophel U, Wangmo S, Dorji T, et al
     Clinical and epidemiological profile of patients with colorectal cancer in Bhutan: a cross-sectional study.
     BMC Cancer. 2025;25:1673.
     PubMed     Abstract available
     
     
     
111. SHEN Y, Bao T, Yuan T, Zhang Y, et al
     Development of a novel angiogenesis-associated gene model for prognosis prediction in colorectal cancer.
     BMC Cancer. 2025;25:1628.
     PubMed    
     
     
     
112. HUANG F, McLeod MC, Irwin RK, Smithson M, et al
     Molecular predictors of treatment resistance and recurrence following neoadjuvant therapy in rectal cancer.
     BMC Cancer. 2025;25:1624.
     PubMed     Abstract available
     
     
     
113. GUSTAVSEN EM, Norderval S, Dorum LM, Stensland E, et al
     Impact of timing of adjuvant chemotherapy initiation on survival for elderly patients with stage III colon cancer in Norway - a register-based cohort study.
     BMC Cancer. 2025;25:1578.
     PubMed     Abstract available
     
     
     
114. LI J, Dong B
     RAS mutations and colorectal cancer metabolism: a metabolomic analysis of tissue samples.
     BMC Cancer. 2025;25:1580.
     PubMed     Abstract available
     
     
     
115. YOU JH, Deng YB, Li YB, Zhang Y, et al
     The surgical effect of inferior mesenteric artery ligation level in rectal cancer and sigmoid colon cancer: a meta-analysis of randomized controlled trials.
     BMC Cancer. 2025;25:1531.
     PubMed     Abstract available
     
     
     
116. ZHOU Q, Zhou C, Zhang G, Xia X, et al
     Age-related differences in adjuvant chemotherapy use and outcomes in stage II colon cancer: a retrospective cohort study.
     BMC Cancer. 2025;25:1527.
     PubMed     Abstract available
     
     
     
117. YE J, Sun B, Xia F, Wang G, et al
     Berberine: a promising strategy to combat cetuximab-resistance in colorectal cancer.
     BMC Cancer. 2025;25:1520.
     PubMed     Abstract available
     
     
     
118. HAN C, Burd C, Plascak J, Tounkara F, et al
     AI-driven chemotoxicity prediction in colorectal cancer: impact of race, SDOH, and biological aging.
     BMC Cancer. 2025;25:1513.
     PubMed     Abstract available
     
     
     
119. GHOLIZADE M, Yazdani E, Hosseini-Baharanchi FS, Nikoofar A, et al
     Variations in radiomic features of the femoral head and neck during helical tomotherapy in prostate and rectal cancer patients.
     BMC Cancer. 2025;25:1509.
     PubMed     Abstract available
     
     
     
120. NEMATI M, Dastghaib S, Hosseinzadeh Z, Molayem M, et al
     Importance of PERK pathway modulation on colorectal cancer management: a systematic review.
     BMC Cancer. 2025;25:1502.
     PubMed     Abstract available
     
     
     
121. ZHENG X, He Y, Tuo Z, Zhu K, et al
     Development of a prognostic risk model for colorectal cancer based on microsatellite stability-associated genes.
     BMC Cancer. 2025;25:1490.
     PubMed     Abstract available
     
     
     September 2025
122. LI SQ, Wang L, Liu XY, Liu XR, et al
     Impact of cardiovascular disease on colorectal cancer morbidity and prognosis.
     BMC Cancer. 2025;25:1448.
     PubMed     Abstract available
     
     
     
123. WYATT LC, Nguyen CH, LeCroy MN, Foster V, et al
     Prevalence of breast, cervical, and colorectal cancer screenings among select New York City populations.
     BMC Cancer. 2025;25:1469.
     PubMed     Abstract available
     
     
     
124. WILSON S, Guittet L, Gardy J, Alves A, et al
     Evolution of microsatellite instability testing in a population-based cohort of patients with colorectal cancer in France in the years leading up to official recommendations.
     BMC Cancer. 2025;25:1450.
     PubMed     Abstract available
     
     
     
125. GOKTAS AYDIN S, Ozguzel B, Bayramova B, Budak E, et al
     Cognitive flexibility, memory, and attention in colorectal cancer: findings from a comprehensive neuropsychological assessment.
     BMC Cancer. 2025;25:1447.
     PubMed     Abstract available
     
     
     
126. WANG M, Di X, Zhang S, Li F, et al
     Prognostic value of integrated inflammatory-nutritional evaluation in neoadjuvant-treated rectal cancer: a retrospective cohort analysis.
     BMC Cancer. 2025;25:1453.
     PubMed     Abstract available
     
     
     
127. NIEMINEN TT, Kuismin O, Laine R, Lepisto A, et al
     Non-truncating BMPR1A variants associated with familial colorectal cancer and adenomatous polyps.
     BMC Cancer. 2025;25:1435.
     PubMed     Abstract available
     
     
     
128. LIN PT, Wu YW
     Highly-accurate prediction of colorectal cancer through low abundance uncultivated genomes recovered using metagenomic co-assembly and binning approach.
     BMC Cancer. 2025;25.
     PubMed     Abstract available
     
     
     
129. TOPI G, Sjolander A, Satapathy SR
     Integrating COX-2, stromal PD-L1, and T-cell infiltration enhances prognostic stratification in colorectal cancer.
     BMC Cancer. 2025;25:1424.
     PubMed     Abstract available
     
     
     
130. LI Y, Sun H, Zhu L
     Pan-cancer analysis of tumor suppressor ZNF132 reveals its diagnostic and prognostic significance with immunomodulatory implications in colorectal cancer.
     BMC Cancer. 2025;25:1416.
     PubMed     Abstract available
     
     
     
131. MUN JY, Han K, Yoo N, Kye BH, et al
     Overall survival following radical surgery and postoperative chemotherapy in colorectal cancer patients aged >/= 70 years: a population-based retrospective cohort study.
     BMC Cancer. 2025;25:1413.
     PubMed     Abstract available
     
     
     August 2025
132. LI X, Zhou X, Chen Y, Liu W, et al
     Global, regional, and national burden of colorectal cancer among women of childbearing age from 1990 to 2021: a systematic analysis based on the global burden of disease study 2021.
     BMC Cancer. 2025;25:1389.
     PubMed     Abstract available
     
     
     
133. CHA Y, Cho SH, Park EY, Lee DE, et al
     Platform study of circulating tumor DNA directed adjuvant chemotherapy in colon cancer (CLAUDIA colon cancer, KCSG CO22-12).
     BMC Cancer. 2025;25:1373.
     PubMed    
     
     
     
134. XIA L, Wang J, Gao J, Cui X, et al
     Integrative multi-omics analysis identifies key genes and colocalized signals associated with colorectal cancer risk.
     BMC Cancer. 2025;25:1372.
     PubMed    
     
     
     
135. BAI M, Liu L, Liu M, Liu X, et al
     Impact of preoperative abdominal MRI staging on outcomes for stage II-III colon cancer: a propensity score-matched cohort study.
     BMC Cancer. 2025;25:1283.
     PubMed     Abstract available
     
     
     
136. YIN X, Geng R, Chen J, Xu B, et al
     Evaluating IL22RA1 expression as a predictive indicator in human colon cancer progression.
     BMC Cancer. 2025;25:1278.
     PubMed     Abstract available
     
     
     
137. ARAS F, Parvizi M, Nalbant OA, Ozkol V, et al
     Evaluation of pre-treatment F-18 FDG PET/CT according to Mandard classification in locally advanced rectal cancer patients undergoing neoadjuvant chemoradiotherapy.
     BMC Cancer. 2025;25:1262.
     PubMed     Abstract available
     
     
     
138. HUANG J, Gong Q, Li Q, Xiao M, et al
     Analysis of the immune microenvironment in colorectal cancer with different KRAS gene subtypes.
     BMC Cancer. 2025;25:1267.
     PubMed     Abstract available
     
     
     
139. LIU H, Jia Z, Xu H, Wang X, et al
     Clinical profiles and health-related quality of life changes after treatment in advanced colorectal cancer patients: a nationwide study in China.
     BMC Cancer. 2025;25:1256.
     PubMed     Abstract available
     
     
     July 2025
140. HANAOKA M, Kagawa H, Ishiguro M, Hirakawa A, et al
     Long-term prognosis of intracorporeal versus extracorporeal anastomosis in stage II/III colorectal cancer (INEX study): study protocol for a multicenter randomized controlled trial in Japan.
     BMC Cancer. 2025;25:1242.
     PubMed     Abstract available
     
     
     
141. FADEL MG, Murray J, Woodfield G, Belluomo I, et al
     Non-invasive breath testing to detect colorectal cancer: protocol for a multicentre, case-control development and validation study (COBRA2 study).
     BMC Cancer. 2025;25:1230.
     PubMed     Abstract available
     
     
     
142. SEO W, Jung SY, Jang Y, Lee K, et al
     Lifestyle factors and colorectal cancer prediction: A nomogram-based model.
     BMC Cancer. 2025;25:1240.
     PubMed     Abstract available
     
     
     
143. LI X, Chen Z, Yin J, Shen X, et al
     Exploring research frontiers and emerging trends of tyrosine kinase inhibitors in the treatment of colorectal cancer.
     BMC Cancer. 2025;25:1235.
     PubMed     Abstract available
     
     
     
144. NATHAN M, Chatzistamatiou K, Gallio N, Cappello C, et al
     Current practices in HPV-related anogenital neoplasia care in Europe - a survey analysis.
     BMC Cancer. 2025;25:1223.
     PubMed     Abstract available
     
     
     
145. PELLATT AJ, Barnett RM, Gnerre S, Edwards K, et al
     Detection of oncogenic fusions in colorectal cancer using a partner-agnostic next-generation sequencing approach.
     BMC Cancer. 2025;25:1201.
     PubMed     Abstract available
     
     
     
146. NIU S, Jiang C, Miao X, Zhang Y, et al
     Association of triglyceride-glucose related indices with colorectal cancer risk among the US population: a cross-sectional study.
     BMC Cancer. 2025;25:1186.
     PubMed     Abstract available
     
     
     
147. LIU Z, Huang S, Xu M, Yu Q, et al
     Development and validation of a histological calculator for anastomotic margins to predict anastomotic failure among rectal cancer patients treated with neoadjuvant chemoradiotherapy.
     BMC Cancer. 2025;25:1181.
     PubMed     Abstract available
     
     
     
148. MOUSAVIKIA SN, M Matin M, Bahreyni Tossi MT, Aghaee-Bakhtiari SH, et al
     Identification and modulation of a PI3K/AKT/mTOR pathway-targeting microRNA in order to increase colorectal cancer cells radiosensitivity in vitro.
     BMC Cancer. 2025;25:1172.
     PubMed     Abstract available
     
     
     
149. LIN X, Bian C, Liang D, Li L, et al
     An in-frame deletion mutation in MLH1 drives Lynch syndrome-associated colorectal cancer.
     BMC Cancer. 2025;25:1165.
     PubMed     Abstract available
     
     
     
150. YANG L, Li Y, Zeng T, Long M, et al
     Gene mutation in cancer patients with diabetes: a real-world retrospective cohort study.
     BMC Cancer. 2025;25:1163.
     PubMed     Abstract available
     
     
     
151. IWAI T, Yamada T, Uehara K, Shinji S, et al
     Evaluating cell-free DNA integrity index as a non-invasive biomarker for neoadjuvant chemotherapy in colorectal cancer patients.
     BMC Cancer. 2025;25:1153.
     PubMed     Abstract available
     
     
     
152. XIAOYANG X, Chunhui Z, Xiaolan Y, Dong Z, et al
     Effect of different types of aerobic exercises on cancer-related fatigue among colorectal cancer patients: a meta-analysis based on randomized controlled trials.
     BMC Cancer. 2025;25:1145.
     PubMed     Abstract available
     
     
     
153. SAGNAK YILMAZ Z, Demir Kececi S, Aydin Mungan S, Saygin I, et al
     Comparison of somatic mutations and clinicopathologic features of micropapillary and non-micropapillary colorectal carcinomas.
     BMC Cancer. 2025;25:1100.
     PubMed     Abstract available
     
     
     
154. HUANG J, Xu L, Cai Y, Tan X, et al
     Certain pMMR colorectal cancer patients should undergo additional MSI-PCR testing to reduce the risk of misdiagnosing MSI-H and Lynch syndrome.
     BMC Cancer. 2025;25:1103.
     PubMed     Abstract available
     
     
     
155. LI N, Gao LJ, Guo KX, Wang J, et al
     NHP2 and PRPF4 are hub genes associated with the prognosis of colorectal cancer.
     BMC Cancer. 2025;25:1088.
     PubMed     Abstract available
     
     
     
156. WANG W, Zhou Z, Cheng X, Chen L, et al
     Preimplantation genetic testing for monogenic disorders to prevent MSH6 germline pathogenic variant related colorectal cancer.
     BMC Cancer. 2025;25:1131.
     PubMed     Abstract available
     
     
     
157. ANSAB M, Razi S, Nisa F, Araib E, et al
     Neoadjuvant chemoradiotherapy with or without PD-1/PD-L1 inhibitors in locally advanced rectal cancer: a systematic review and meta-analysis.
     BMC Cancer. 2025;25:1084.
     PubMed     Abstract available
     
     
     
158. RUSS E, Ziemons J, Hillege LE, van Kuijk SMJ, et al
     Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer-study protocol of the OPTIMA study.
     BMC Cancer. 2025;25:1129.
     PubMed     Abstract available
     
     
     
159. GUO Q, Li J, Wei Z, Xu J, et al
     Risk factors and prediction of distant metastasis (DM) of colon adenocarcinoma: a logistic regression and machine learning study based on surveillance, epidemiology, and end results (SEER) database.
     BMC Cancer. 2025;25:1047.
     PubMed     Abstract available
     
     
     June 2025
160. TISELIUS C, Johansen F, Rosenblad A, Smedh K, et al
     Health-related quality of life is a significant prognostic factor for recurrence and overall survival in patients with colon cancer.
     BMC Cancer. 2025;25:1016.
     PubMed     Abstract available
     
     
     
161. WANG Y, Lu J, Huang D, Chen P, et al
     Explosive tumor growth in a patient with colon cancer is associated with reduced neoantigen levels and decreased interferon-gamma (IFN-gamma) signaling.
     BMC Cancer. 2025;25:1005.
     PubMed     Abstract available
     
     
     
162. MA A, Zhai C, He Q, Wang W, et al
     ENTR1 affects the progression of colon cancer by regulating energy metabolism under the influence of glycolysis.
     BMC Cancer. 2025;25:992.
     PubMed     Abstract available
     
     
     
163. SABERPOUR M, Maqsoodi R, Bakhshi B
     Anti-cancer properties of chitosan /Lactobacillus acidophilus secretome nanoparticle on signaling pathways of colorectal cancer in colon adenocarcinoma (Caco-2) cell line.
     BMC Cancer. 2025;25:983.
     PubMed     Abstract available
     
     
     
164. ZENG Z, Ke Y, Huang F, Li H, et al
     Targeting INF2 with DiosMetin 7-O-beta-D-Glucuronide: a new stratagem for colorectal cancer therapy.
     BMC Cancer. 2025;25:982.
     PubMed     Abstract available
     
     
     
165. XIE X, Wang W, Zhang H, Zhao S, et al
     Cholesterol-induced colorectal cancer progression and its mitigation through gut microbiota remodeling and simvastatin treatment.
     BMC Cancer. 2025;25:977.
     PubMed     Abstract available
     
     
     May 2025
166. VAHED IE, Moshgelgosha M, Kor A, Minadi M, et al
     The role of Adiponectin and Leptin in Colorectal Cancer and Adenoma: a systematic review and meta-analysis.
     BMC Cancer. 2025;25:968.
     PubMed     Abstract available
     
     
     
167. PHAM HT, Nguyen TA, Ba TL, Tran VNM, et al
     Quality of life in patients with metastatic colorectal cancer receiving cytotoxic and cytotoxic plus targeted therapy.
     BMC Cancer. 2025;25:957.
     PubMed     Abstract available
     
     
     
168. JEON Y, Jung M, Jeong B, Lee H, et al
     Phase I study of the safety, tolerability, and potential therapeutic dose of OMT-110 for patients with refractory metastatic Colorectal Cancer.
     BMC Cancer. 2025;25:937.
     PubMed     Abstract available
     
     
     
169. SHIRZAD S, Eterafi M, Karimi Z, Barazesh M, et al
     MicroRNAs involved in colorectal cancer, a rapid mini-systematic review.
     BMC Cancer. 2025;25:934.
     PubMed     Abstract available
     
     
     
170. LJUNGGREN M, Dietrich CE, Rosander E, Palmer G, et al
     Correction: Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study.
     BMC Cancer. 2025;25:929.
     PubMed    
     
     
     
171. ZHANG X, Zhang J, Zhao C, Cai Y, et al
     Effects of individualized PEEP on pulmonary function, cerebral blood flow and postoperative cognitive function in patients undergoing laparoscopic radical resection of rectal cancer.
     BMC Cancer. 2025;25:927.
     PubMed     Abstract available
     
     
     
172. CASTANEDA-AVILA MA, Latoni-Guillermety D, Sabatino M, Ortiz-Ortiz KJ, et al
     Challenges oncologists face when caring for hispanics living in puerto rico with colorectal cancer and multiple chronic conditions.
     BMC Cancer. 2025;25:898.
     PubMed     Abstract available
     
     
     
173. ASEFI M, Rezvani N, Saidijam M, Soltanian AR, et al
     Evaluation of epigenetic silencing of the miR-139-5p gene in the pathogenesis of colorectal cancer and its diagnostic biomarker capability in plasma samples.
     BMC Cancer. 2025;25:877.
     PubMed     Abstract available
     
     
     
174. SAMUELSSON M, Edman K, Neziraj M, Ericsson A, et al
     Aiming for survival: a qualitative single case study of support for family members across the care process in outpatient colorectal cancer care.
     BMC Cancer. 2025;25:856.
     PubMed     Abstract available
     
     
     
175. ZHANG X, Zhao T, Wu C, Shen H, et al
     LncRNA CASC19 promotes the growth and glycolysis of colorectal cancer cells and tumor metastasis in mice.
     BMC Cancer. 2025;25:829.
     PubMed     Abstract available
     
     
     April 2025
176. LI W, Liu B, Xiang X, Zhang Q, et al
     Lymphovascular invasion affects prognosis of colorectal cancer liver metastasis underwent primary resection: a propensity score matching analysis.
     BMC Cancer. 2025;25:793.
     PubMed     Abstract available
     
     
     
177. WISMAYER R, Matthews R, Whalley C, Kiwanuka J, et al
     The role of MLH1, MSH2 and MSH6 in the development of colorectal cancer in Uganda.
     BMC Cancer. 2025;25:792.
     PubMed     Abstract available
     
     
     
178. CHIGVINADZE N, Pantsulaia I, Lejava T, Aladashvili A, et al
     Suppressor protein plasma levels and inflammatory indices in colorectal cancer patients.
     BMC Cancer. 2025;25:774.
     PubMed     Abstract available
     
     
     
179. LU L, Li H, Yin H, Wang F, et al
     The expression of PRMT5 is associated with postoperative chemotherapeutic outcome in colon cancer.
     BMC Cancer. 2025;25:760.
     PubMed     Abstract available
     
     
     
180. MENG B, Ma Y, Wang Y, Zhou M, et al
     Dual-Time-Point (18)F-FDG PET/CT imaging in the diagnosis of colorectal carcinoma or advanced adenoma in patients with fixed focal colorectal (18)F-FDG uptake.
     BMC Cancer. 2025;25:755.
     PubMed     Abstract available
     
     
     
181. GEBRELIBANOS H, Taye G, Wondimagegnehu A, Feyisa JD, et al
     The quality of life of colorectal cancer patients attending the cancer center in addis Ababa, Ethiopia.
     BMC Cancer. 2025;25:754.
     PubMed     Abstract available
     
     
     
182. LI S, Wang H, Xu XQ, Li WM, et al
     Association of pre-diagnosis plasma proteomic contexture with overall survival of early- and late-stage colon cancer patients.
     BMC Cancer. 2025;25:744.
     PubMed     Abstract available
     
     
     
183. VALLADARES-AYERBES M, Toledano-Fonseca M, Grana B, Jimenez-Fonseca P, et al
     Associations of blood RNA biomarkers and circulating tumour cells in patients with previously untreated metastatic colorectal cancer.
     BMC Cancer. 2025;25:743.
     PubMed     Abstract available
     
     
     
184. WANG S, Jin X, Ba Y, Liu W, et al
     Differentiating rectal cancer grades using virtual magnetic resonance elastography and fractional order calculus diffusion model.
     BMC Cancer. 2025;25:734.
     PubMed     Abstract available
     
     
     
185. HAYASHI M, Nakamura K, Harada S, Tanaka M, et al
     GLUT1 inhibition by BAY-876 induces metabolic changes and cell death in human colorectal cancer cells.
     BMC Cancer. 2025;25:716.
     PubMed     Abstract available
     
     
     
186. GAO Y, Hu P, Wu N, Tan F, et al
     A study protocol for the CHinA National CancEr screening (CHANCES) trial: a randomized controlled study to compare the screening strategies for lung cancer and colorectal cancer.
     BMC Cancer. 2025;25:727.
     PubMed     Abstract available
     
     
     
187. XUE JS, Maimaitiming N, Zhang BL, Xu BW, et al
     Prognostic analysis of patients with CRLM based on CRS score: a single-center retrospective study.
     BMC Cancer. 2025;25:718.
     PubMed     Abstract available
     
     
     
188. QIU Z, Cheng Y, Liu H, Li T, et al
     Screening colorectal cancer associated autoantigens through multi-omics analysis and diagnostic performance evaluation of corresponding autoantibodies.
     BMC Cancer. 2025;25:713.
     PubMed     Abstract available
     
     
     
189. LI R, Sun X, Yu Z, Li P, et al
     Identification of predictors for lymph node metastasis in T2 colorectal cancer: retrospective cohort study from a high-volume hospital.
     BMC Cancer. 2025;25:700.
     PubMed     Abstract available
     
     
     
190. ZHENG QQ, Lin WF
     Inhibition of miR-325 inhibits KIF20B expression and the colorectal cancer cells' invasion & proliferation.
     BMC Cancer. 2025;25:680.
     PubMed     Abstract available
     
     
     
191. HAGHIGHI L, Dalimi A, Pirestani M, Ghaffarifar F, et al
     The effect of Entamoeba histolytica lectin antigen and microRNA-643 on the development of microsatellite instability (MSI) in colorectal adenocarcinoma.
     BMC Cancer. 2025;25:663.
     PubMed     Abstract available
     
     
     
192. CUI Y, Mei J, Zhao S, Zhu B, et al
     Identification of a PANoptosis-related long noncoding rna risk signature for prognosis and immunology in colon adenocarcinoma.
     BMC Cancer. 2025;25:662.
     PubMed     Abstract available
     
     
     
193. AROLDI F, Elez E, Andre T, Perkins G, et al
     A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC).
     BMC Cancer. 2025;25:658.
     PubMed     Abstract available
     
     
     
194. LIU T, Jiao S, Gao S, Shi Y, et al
     Optimal lymph node yield for long-term survival in elderly patients with right-sided colon cancer: a large population-based cohort study.
     BMC Cancer. 2025;25:590.
     PubMed     Abstract available
     
     
     
195. HAUAN M, Rylander C, Skeie G
     Sweet beverages and the risk of colorectal cancer: the Norwegian Women and Cancer Study.
     BMC Cancer. 2025;25:592.
     PubMed     Abstract available
     
     
     
196. SAM I, Dang W, Iu N, Luo Z, et al
     Barriers and facilitators to anal cancer screening among men who have sex with men: a systematic review with narrative synthesis.
     BMC Cancer. 2025;25:586.
     PubMed     Abstract available
     
     
     March 2025
197. ZHU Z, Jiang D, Jiang Y, Quan J, et al
     Dentate line invasion is a risk factor for locoregional recurrence and distant metastasis following abdominoperineal resection in rectal cancer: a single-centre retrospective cohort study based on 1854 cases.
     BMC Cancer. 2025;25:574.
     PubMed     Abstract available
     
     
     
198. FU C, Fu J, Liu C, Yu Z, et al
     Synergistic potential of CDH3 in targeting CRC metastasis and enhancing immunotherapy.
     BMC Cancer. 2025;25:560.
     PubMed     Abstract available
     
     
     
199. SHAHABI F, Abdollahi A, Zarif-Sadeghian M, Ziyaie D, et al
     Rectal prolapse as an initial presentation of colorectal cancer: a systematic review.
     BMC Cancer. 2025;25:553.
     PubMed     Abstract available
     
     
     
200. BOUDNA M, Blavet N, Samoilenko T, Machackova T, et al
     Analysis of extracellular vesicles of frequently used colorectal cancer cell lines.
     BMC Cancer. 2025;25:555.
     PubMed     Abstract available
     
     
     
201. WANG X, Wang Y, Chen Z, Zheng Z, et al
     Proficient surgeons enhance conversion rates and sphincter preservation in robotic rectal cancer surgery with comparable long-term outcomes: a comparative study with laparoscopy in a large-volume center in China.
     BMC Cancer. 2025;25:545.
     PubMed     Abstract available
     
     
     
202. WU Y, Qu Z, Wu Z, Zhuang J, et al
     Multiple primary malignancies and gut microbiome.
     BMC Cancer. 2025;25:516.
     PubMed     Abstract available
     
     
     
203. LONG C, Cheng J, Feng M, Yan B, et al
     Association of the tumor microenvironment collagen score and immunoscore with colon cancer lymph node metastasis.
     BMC Cancer. 2025;25:506.
     PubMed     Abstract available
     
     
     
204. WANG J, Gong Z, Liu J, Wang W, et al
     Fc fragment of IgG binding protein suppresses tumor growth by stabilizing wild type P53 in colorectal cancer cells.
     BMC Cancer. 2025;25:507.
     PubMed     Abstract available
     
     
     
205. WANG Y, Yang Z, Li Z, Huang L, et al
     Proteomics-driven discovery of LCAT as a novel biomarker for liver metastasis in colorectal cancer.
     BMC Cancer. 2025;25:480.
     PubMed     Abstract available
     
     
     
206. NOURBAKHSH ST, Mirzaei SA, Mohamadhashem F, Naghizadeh MM, et al
     Pathological expression of mitochondrial genome-derived circRNA SCAR/mc-COX2 and its ceRNA network in colorectal cancer: implications for clinical significance.
     BMC Cancer. 2025;25:466.
     PubMed     Abstract available
     
     
     
207. ZHANG J, Dong B, Dong H, Guo D, et al
     Gender-specific differences in factors influencing supportive care needs in colorectal cancer patients.
     BMC Cancer. 2025;25:471.
     PubMed     Abstract available
     
     
     
208. YUN D, Yang JH, Yang S, Sim JA, et al
     Novel genetic loci and functional properties of immune-related genes for colorectal cancer survival in Korea.
     BMC Cancer. 2025;25:456.
     PubMed     Abstract available
     
     
     
209. HOFSLI E, Saetrom P, Ness-Jensen E, Surcel HM, et al
     Can circulating microRNAs predict colorectal cancer? Results from a nested case-control study of pre-diagnostic serum samples from two prospective biobanks.
     BMC Cancer. 2025;25:455.
     PubMed     Abstract available
     
     
     
210. YANG M, Nebozhyn MV, Schell MJ, Gandhi N, et al
     Identifying distinct prognostic and predictive contributions of tumor epithelium versus tumor microenvironment in colorectal cancer.
     BMC Cancer. 2025;25:441.
     PubMed     Abstract available
     
     
     
211. WANG Y, Jia R, Si H, Ma Y, et al
     Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer.
     BMC Cancer. 2025;25:422.
     PubMed     Abstract available
     
     
     
212. LI Z, Feng C, Liu H, Liu Y, et al
     Factors influencing clinical decision-making and health-related quality of life changes in colorectal cancer patients receiving targeted therapy: a multicenter study in China.
     BMC Cancer. 2025;25:423.
     PubMed     Abstract available
     
     
     
213. POWER S, Wooldrage K, Thomas-Gibson S, Cross AJ, et al
     The impact of patient-reported factors of endoscopic screening experience on attendance at future examinations and distal colorectal cancer incidence.
     BMC Cancer. 2025;25:409.
     PubMed     Abstract available
     
     
     
214. ALMILAJI O, Sharples L, Aggarwal A, Cromwell D, et al
     Value of hospital administrative data linked to national cancer registry records to identify metastatic disease at time of primary diagnosis in colorectal cancer patients: a study using national data in England.
     BMC Cancer. 2025;25:407.
     PubMed     Abstract available
     
     
     
215. CHEN C, Fu Q, Wang L, Tanaka S, et al
     Establishment of a novel mouse model of colorectal cancer by orthotopic transplantation.
     BMC Cancer. 2025;25:405.
     PubMed     Abstract available
     
     
     
216. LI H, Sun W, Fu S, Wang J, et al
     Prognostic value of the preoperative prognostic nutritional and systemic immunoinflammatory indexes in patients with colorectal cancer.
     BMC Cancer. 2025;25:403.
     PubMed     Abstract available
     
     
     
217. LI Y, Zhuang M, Mei S, Hu G, et al
     Gut microbiota, immune cell, colorectal cancer association mediators: a Mendelian randomization study.
     BMC Cancer. 2025;25:396.
     PubMed     Abstract available
     
     
     
218. NAVARRO-SANCHEZ A, Nieto-Vitoria MA, Lopez-Lopez JA, Martinez-Crespo JJ, et al
     Is the oral pathogen, Porphyromona gingivalis, associated to colorectal cancer?: a systematic review.
     BMC Cancer. 2025;25:395.
     PubMed     Abstract available
     
     
     
219. LIU R, Tang L, Liu Y, Hu H, et al
     Causal relationship between immune cell signatures and colorectal cancer: a bi-directional, two-sample mendelian randomization study.
     BMC Cancer. 2025;25:387.
     PubMed     Abstract available
     
     
     February 2025
220. LENG W, Wen Z, Wang H, Cao P, et al
     Raltitrexed, S-1 and fruquintinib (RSF) in the treatment of refractory metastatic colorectal cancer: study protocol for a multicenter, prospective, single-arm, phase II trial.
     BMC Cancer. 2025;25:376.
     PubMed     Abstract available
     
     
     
221. GAO F, Zhang Q, Teng F, Li L, et al
     Assessing the causal association between 731 immunophenotypes and the risk of colorectal cancer: a Mendelian randomization study.
     BMC Cancer. 2025;25:335.
     PubMed     Abstract available
     
     
     
222. PONVILAWAN B, Sakornsakolpat P, Pongpaibul A, Roothumnong E, et al
     Comprehensive genomic analysis in sporadic early-onset colorectal adenocarcinoma patients.
     BMC Cancer. 2025;25:349.
     PubMed     Abstract available
     
     
     
223. AZEEM M, Ur Rehman A, Rasheed S, Shahzad A, et al
     The impact of combining cetuximab with the traditional chemotherapy regimens on clinical effectiveness in metastatic colorectal cancer: a systematic review and meta-analysis.
     BMC Cancer. 2025;25:331.
     PubMed     Abstract available
     
     
     
224. FENG R, Li X, Li B, Luan T, et al
     Integrating transcriptomics and scPagwas analysis predicts naive CD4 T cell-related gene DRAM2 as a potential biomarker and therapeutic target for colorectal cancer.
     BMC Cancer. 2025;25:317.
     PubMed     Abstract available
     
     
     
225. KOCH PF, Ludwig K, Hillebrandt KH, Freitag H, et al
     Gender-based variations in surgical management of colorectal liver metastases: comprehensive analysis.
     BMC Cancer. 2025;25:315.
     PubMed     Abstract available
     
     
     
226. LI L, Zhang R, Li Y
     Up-regulation of m(6)A writer METTL14 inhibits tumorigenesis by suppressing glycolysis in colorectal cancer.
     BMC Cancer. 2025;25:305.
     PubMed     Abstract available
     
     
     
227. ZHU J, Gao Y, Zhang C, Wu Y, et al
     Prognostic significance of preoperative CT-based sarcopenia in locally advanced rectal cancer: a multicenter retrospective study.
     BMC Cancer. 2025;25:261.
     PubMed     Abstract available
     
     
     
228. LI Z, Aihemaiti Y, Yang Q, Ahemai Y, et al
     Survival machine learning model of T1 colorectal postoperative recurrence after endoscopic resection and surgical operation: a retrospective cohort study.
     BMC Cancer. 2025;25:262.
     PubMed     Abstract available
     
     
     
229. CHEN J, Hu Q, Zhang C, Zhao A, et al
     Tendomodulin in pan-cancer analysis: exploring its impact on immune modulation and uncovering functional insights in colorectal cancer.
     BMC Cancer. 2025;25:239.
     PubMed     Abstract available
     
     
     
230. ZHANG X, Xu Z, Shang L, Yang Q, et al
     Global burden of colorectal cancer attributable to metabolic risks from 1990 to 2021, with predictions to 2046.
     BMC Cancer. 2025;25:228.
     PubMed     Abstract available
     
     
     
231. LEE JG, Park I, Lee H, Nam S, et al
     Correction: Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patients.
     BMC Cancer. 2025;25:214.
     PubMed    
     
     
     
232. KYE BH, Kim JH, Kim HJ, Lee YS, et al
     Oncologic oUTcomes of neoadjuvant chemotherapy for obSTructive colon cAncer after steNt decompression (OUTSTAND trial); A study protocol of multicenter non-inferiority randomized controlled trial.
     BMC Cancer. 2025;25:194.
     PubMed     Abstract available
     
     
     
233. LIU ZM, Yao QJ, Pei F, He F, et al
     Efficacy and safety of reduced-port laparoscopic surgery versus conventional laparoscopic surgery for colorectal cancer.
     BMC Cancer. 2025;25:187.
     PubMed     Abstract available
     
     
     January 2025
234. YE M, Xu G, Zhang L, Kong Z, et al
     Meta Analysis of Methylenetetrahydrofolate Reductase (MTHFR) C677T polymorphism and its association with folate and colorectal cancer.
     BMC Cancer. 2025;25:169.
     PubMed     Abstract available
     
     
     
235. BAGREZAEI F, Gargari BP, Zamiri RE, Safaiyan A, et al
     Assessment of the quality of life in metastatic colorectal cancer patients with KRAS gene mutant: a case-control study.
     BMC Cancer. 2025;25:158.
     PubMed     Abstract available
     
     
     
236. LEE JG, Park I, Lee H, Nam S, et al
     Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patients.
     BMC Cancer. 2025;25:150.
     PubMed     Abstract available
     
     
     
237. HOU Z, Qin N, He Y, Chen J, et al
     Association between colorectal cancer and arthritis among Americans in 2005-2016.
     BMC Cancer. 2025;25:140.
     PubMed     Abstract available
     
     
     
238. YONEZAWA A, Shimomura K, Okamoto K, Takeda H, et al
     Inhibition of BRD4 attenuated IFNgamma-induced apoptosis in colorectal cancer organoids.
     BMC Cancer. 2025;25:136.
     PubMed     Abstract available
     
     
     
239. WALLE GT, Kitaw TA, Adane S
     Incidence and determinants of mortality among patients with colorectal cancer in oncology centers of Amhara region, Ethiopia, 2024: multicenter retrospective follow up study.
     BMC Cancer. 2025;25:102.
     PubMed     Abstract available
     
     
     
240. NISHI M, Yamashita S, Takasu C, Wada Y, et al
     Role of mast cell in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
     BMC Cancer. 2025;25:99.
     PubMed     Abstract available
     
     
     
241. SHEN J, Gong X, Ren H, Tang X, et al
     Identification and validation of CDK1 as a promising therapeutic target for Eriocitrin in colorectal cancer: a combined bioinformatics and experimental approach.
     BMC Cancer. 2025;25:76.
     PubMed     Abstract available
     
     
     
242. BOVELL AAN, Ramaliba T, Goodwin SO, Phillip JC, et al
     Incidence, trends and patterns of female breast, cervical, colorectal and prostate cancers in Antigua and Barbuda, 2017-2021: a retrospective study.
     BMC Cancer. 2025;25:72.
     PubMed     Abstract available
     
     
     
243. ZHAO Y, Xun D, Chen J, Qi X, et al
     A novel machine learning-based immune prognostic signature for improving clinical outcomes and guiding therapy in colorectal cancer: an integrated bioinformatics and experimental study.
     BMC Cancer. 2025;25:65.
     PubMed     Abstract available
     
     
     
244. DELI H, Vakili-Ghartavol Z, Asgari Y, Tavoosidana G, et al
     The expression of exosomal and cellular miRNAs in predicting oxaliplatin resistance in colorectal cancer cells: an in silico and in vitro study.
     BMC Cancer. 2025;25:46.
     PubMed     Abstract available
     
     
     
245. EVERATT R, Kuzmickiene I, Brasiuniene B, Vincerzevskiene I, et al
     Postdiagnostic use of antihypertensive medications and survival in colorectal, lung, corpus uteri, melanoma and kidney cancer patients with hypertension.
     BMC Cancer. 2025;25:38.
     PubMed     Abstract available
     
     
     
246. CHEN D, Ma Y, Li J, Wen L, et al
     Causality between insulin use and malignant tumors of the digestive system: a two-sample mendelian randomized study.
     BMC Cancer. 2025;25:31.
     PubMed     Abstract available
     
     
     
247. YANG J, Cao Z, Yu C, Cui W, et al
     Identification of a mitophagy-related gene signature for predicting overall survival and response to immunotherapy in rectal cancer.
     BMC Cancer. 2025;25:15.
     PubMed     Abstract available
     
     
     
248. TAKAHASHI T, Shigeyasu K, Kondo Y, Takeda S, et al
     Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients.
     BMC Cancer. 2025;25:1.
     PubMed     Abstract available
     
     
     December 2024
249. WANG Z, Han W, Fei R, Hu Y, et al
     Age, frequency, and strategy optimization for organized colorectal cancer screening: a decision analysis conducted in China for the years 2023-2038.
     BMC Cancer. 2024;24:1596.
     PubMed     Abstract available
     
     
     
250. ZHANG Y, Huang Y, Xu M, Zhuang J, et al
     Pathomics-based machine learning models for predicting pathological complete response and prognosis in locally advanced rectal cancer patients post-neoadjuvant chemoradiotherapy: insights from two independent institutional studies.
     BMC Cancer. 2024;24:1580.
     PubMed     Abstract available
     
     
     
251. DANG W, Wu S, Liu X, Shen H, et al
     Association between quantitative CT body composition analysis and prognosis in cetuximab-based first-line treatment for advanced colorectal cancer patients.
     BMC Cancer. 2024;24:1579.
     PubMed     Abstract available
     
     
     
252. ZHOU X, Dai J, Lu Y, Zhao Q, et al
     Whole slide image based prognosis prediction in rectal cancer using unsupervised artificial intelligence.
     BMC Cancer. 2024;24:1523.
     PubMed     Abstract available
     
     
     
253. LIANG L, Xu N, Ding L, Li X, et al
     Combined inflammation-related biomarkers and clinicopathological features for the prognosis of stage II/III colorectal cancer by machine learning.
     BMC Cancer. 2024;24:1548.
     PubMed     Abstract available
     
     
     
254. TAKASU C, Morine Y, Yoshikawa K, Tokunaga T, et al
     Impact of pure desmoplastic histological growth patterns in colorectal liver metastasis.
     BMC Cancer. 2024;24:1528.
     PubMed     Abstract available
     
     
     
255. LI H, Chen J, Liu Z, Pan L, et al
     Construction of a novel copper-induced-cell-death-related gene signature for prognosis in colon cancer, with focus on KIF7.
     BMC Cancer. 2024;24:1532.
     PubMed     Abstract available
     
     
     
256. DOS REIS MB, Dos Santos W, de Carvalho AC, Lima AB, et al
     Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay.
     BMC Cancer. 2024;24:1547.
     PubMed     Abstract available
     
     
     November 2024
257. LIU C, Xie J, Ye B, Zhong J, et al
     Unraveling the link between sterol ester and colorectal cancer: a two-sample mendelian randomization study.
     BMC Cancer. 2024;24:1462.
     PubMed     Abstract available
     
     
     
258. LI M, Li Z, Wu X, Yubo Pan, et al
     Exploring the correlation between Tom1L1 and the efficacy of neoadjuvant chemotherapy for locally progressive mid-low rectal cancer.
     BMC Cancer. 2024;24:1413.
     PubMed     Abstract available
     
     
     
259. CHEN Z, Cao H, Zhang J, Zhong W, et al
     The impact of preoperative treatment on mismatch repair protein and HER2 expression in colorectal cancer: an analysis of paired samples.
     BMC Cancer. 2024;24:1407.
     PubMed     Abstract available
     
     
     
260. WEI GX, Zhou YW, Dong C, Zhang T, et al
     Clinicopathologic features and treatment efficacy of patients with BRAF V600E-mutated metastatic colorectal cancer: a multi-center real-world propensity score matching study.
     BMC Cancer. 2024;24:1395.
     PubMed     Abstract available
     
     
     
261. CUI F, Chen Y, Wu X, Zhao W, et al
     Mesenchymal stem cell-derived exosomes carrying miR-486-5p inhibit glycolysis and cell stemness in colorectal cancer by targeting NEK2.
     BMC Cancer. 2024;24:1356.
     PubMed     Abstract available
     
     
     October 2024
262. LIU S, Teng F, Lu Y, Zhu Y, et al
     Ethoxy-erianin phosphate inhibits angiogenesis in colorectal cancer by regulating the TMPO-AS1/miR-126-3p/PIK3R2 axis and inactivating the PI3k/AKT signaling pathway.
     BMC Cancer. 2024;24:1275.
     PubMed     Abstract available
     
     
     
263. NZITAKERA A, Uwamariya D, Kato H, Surwumwe JB, et al
     TP53 mutation status and consensus molecular subtypes of colorectal cancer in patients from Rwanda.
     BMC Cancer. 2024;24:1266.
     PubMed     Abstract available
     
     
     
264. RASCHZOK N, Moosburner S, Blank M, Krenzien F, et al
     Is interval chemotherapy safe and does it improve the outcome of patients with colorectal liver metastases undergoing multimodal two-stage hepatectomy? - A systematic literature review.
     BMC Cancer. 2024;24:1260.
     PubMed     Abstract available
     
     
     
265. BRENNE SS, Madsen PH, Pedersen IS, Hveem K, et al
     The prognostic role of circulating tumour DNA detected prior to clinical diagnosis of colorectal cancer in the HUNT study.
     BMC Cancer. 2024;24:1251.
     PubMed     Abstract available
     
     
     
266. GUO T, Liu K, Guo Y, Zhang H, et al
     CapeOX as neoadjuvant chemotherapy for locally advanced rectal cancer: might less be more?
     BMC Cancer. 2024;24:1248.
     PubMed     Abstract available
     
     
     
267. CAI C, Zhang X, Sun X, Wang H, et al
     Node-sparing modified short-course Radiotherapy Combined with CAPOX and Tislelizumab for locally Advanced MSS of Middle and low rectal Cancer (mRCAT): an open-label, single-arm, prospective, multicentre clinical trial.
     BMC Cancer. 2024;24:1247.
     PubMed     Abstract available
     
     
     
268. GUO T, Cheng B, Li Y, Li Y, et al
     A radiomics model for predicting perineural invasion in stage II-III colon cancer based on computer tomography.
     BMC Cancer. 2024;24:1226.
     PubMed     Abstract available
     
     
     September 2024
269. LIU Y, Ming H, Xu L, Li L, et al
     DNA methylation analysis of the SDC2, SEPT9 and VIM genes in fecal DNA for colorectal cancer diagnosis.
     BMC Cancer. 2024;24:1205.
     PubMed     Abstract available
     
     
     
270. ZHOU J, Cui M, Liang J, Zhao J, et al
     ZYG11B participates in the modulation of colorectal cancer cell proliferation and immune infiltration and is a prognostic biomarker.
     BMC Cancer. 2024;24:1203.
     PubMed     Abstract available
     
     
     
271. WISMAYER R, Matthews R, Whalley C, Kiwanuka J, et al
     Determination of the frequency and distribution of APC, PIK3CA, and SMAD4 gene mutations in Ugandan patients with colorectal cancer.
     BMC Cancer. 2024;24:1212.
     PubMed     Abstract available
     
     
     
272. ZHU Z, Li J, Fa Z, Xu X, et al
     Functional gene signature offers a powerful tool for characterizing clinicopathological features and depicting tumor immune microenvironment of colorectal cancer.
     BMC Cancer. 2024;24:1199.
     PubMed     Abstract available
     
     
     
273. MATHUR A, Bareja C, Mittal M, Singh A, et al
     Targeting cellular plasticity: esculetin-driven reversion of stem cell-like characteristics and EMT phenotype in transforming cells with sequential p53/p73 knockdowns.
     BMC Cancer. 2024;24:1164.
     PubMed     Abstract available
     
     
     
274. HASSAN S, Mirza T, Khatoon A, Bukhari U, et al
     BRAF mutations and the association of V600E with CD133 and CDX2 expression in a Pakistani colorectal carcinoma cohort.
     BMC Cancer. 2024;24:1162.
     PubMed     Abstract available
     
     
     
275. WANG X, Wang H, He H, Lv K, et al
     Clinicopathological and prognostic features of colorectal mucinous adenocarcinomas: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:1161.
     PubMed     Abstract available
     
     
     
276. TANG Y, Fan Y
     Combined KRAS and TP53 mutation in patients with colorectal cancer enhance chemoresistance to promote postoperative recurrence and metastasis.
     BMC Cancer. 2024;24:1155.
     PubMed     Abstract available
     
     
     
277. HOANG T, Cho S, Choi JY, Kang D, et al
     Genetically predicted dietary intake and risks of colorectal cancer: a Mendelian randomisation study.
     BMC Cancer. 2024;24:1153.
     PubMed     Abstract available
     
     
     
278. ZHU J, Zhi S, Zeng J, Zhou S, et al
     Development and validation of a TRIM27-based nomogram for predicting metachronous liver metastasis and prognosis in postoperative colorectal cancer patients.
     BMC Cancer. 2024;24:1142.
     PubMed     Abstract available
     
     
     
279. DENG W, Xiong X, Lu M, Huang S, et al
     Curcumin suppresses colorectal tumorigenesis through restoring the gut microbiota and metabolites.
     BMC Cancer. 2024;24:1141.
     PubMed     Abstract available
     
     
     
280. GAMAGE BD, Ranasinghe D, Sahankumari A, Malavige GN, et al
     Metagenomic analysis of colonic tissue and stool microbiome in patients with colorectal cancer in a South Asian population.
     BMC Cancer. 2024;24:1124.
     PubMed     Abstract available
     
     
     
281. ZHANG W, Hou Z, Zhang L, Hong X, et al
     A log odds of positive lymph nodes-based predictive model effectively forecasts prognosis and guides postoperative adjuvant chemotherapy duration in stage III colon cancer: a multi-center retrospective cohort study.
     BMC Cancer. 2024;24:1088.
     PubMed     Abstract available
     
     
     
282. CHENG Y, Teng Z, Zhang Y, Jin B, et al
     Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II study.
     BMC Cancer. 2024;24:1082.
     PubMed     Abstract available
     
     
     
283. OUYANG Z, Chen P, Zhang M, Wu S, et al
     Arginine on immune function and post-operative obstructions in colorectal cancer patients: a meta-analysis.
     BMC Cancer. 2024;24:1089.
     PubMed     Abstract available
     
     
     August 2024
284. TONGOL E, Kang P, Cheng V, Gastonguay L, et al
     What are the experiences of colorectal cancer patients with biomarker testing in Canada?: a mixed methods study.
     BMC Cancer. 2024;24:1076.
     PubMed     Abstract available
     
     
     
285. WANG Y, Wei Y, Huang J, Li X, et al
     Prognostic value of matrix metalloproteinase-2 protein and matrix metalloproteinase-9 protein in colorectal cancer: a meta-analysis.
     BMC Cancer. 2024;24:1065.
     PubMed     Abstract available
     
     
     
286. FENG Y, Wang K, Fan J, Wu X, et al
     Mindfulness intervention, homogeneous medical concept, and concentrated solution nursing for colorectal cancer patients: a retrospective study.
     BMC Cancer. 2024;24:1055.
     PubMed     Abstract available
     
     
     
287. NOBIN H, Garvin S, Hagman H, Nodin B, et al
     The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types.
     BMC Cancer. 2024;24:1051.
     PubMed     Abstract available
     
     
     
288. CAI W, Li Z, Liu B, Cao Y, et al
     A predictive model for colorectal cancer complicated with intestinal obstruction based on specific inflammation score.
     BMC Cancer. 2024;24:1035.
     PubMed     Abstract available
     
     
     
289. KUSUNOKI C, Uemura M, Osaki M, Takiguchi N, et al
     Postoperative venous thromboembolism after surgery for locally recurrent rectal cancer.
     BMC Cancer. 2024;24:1027.
     PubMed     Abstract available
     
     
     
290. HAGHI NAVAND A, Jalilian S, Ahmadi Angali K, Karimi Babaahmadi M, et al
     A new evaluation of the rearranged non-coding control region of JC virus in patients with colorectal cancer.
     BMC Cancer. 2024;24:1001.
     PubMed     Abstract available
     
     
     
291. MA Y, Zhang J, Wei C, Wang F, et al
     Identification and experimental verification of a biomarker by combining the unfolded protein response with the immune cells in colon cancer.
     BMC Cancer. 2024;24:978.
     PubMed     Abstract available
     
     
     
292. LI X, Chen Y, Liang Y, Shi W, et al
     5-Fluorouracil resistance due to sphingosine kinase 2 overexpression in colorectal cancer is associated with myeloid-derived suppressor cell-mediated immunosuppressive effects.
     BMC Cancer. 2024;24:983.
     PubMed     Abstract available
     
     
     
293. ZENG X, Li C, Yu M, Zhang R, et al
     Laparoscopic versus open surgery for rectal neuroendocrine tumors: a multicenter real-world study.
     BMC Cancer. 2024;24:956.
     PubMed     Abstract available
     
     
     
294. BEKAII-SAAB T, Khan N, Ostojic H, Jiao X, et al
     Real-world dosing of regorafenib and outcomes among patients with metastatic colorectal cancer: a retrospective analysis using US claims data.
     BMC Cancer. 2024;24:939.
     PubMed     Abstract available
     
     
     July 2024
295. CHU S, Ren X, Cao L, Ma C, et al
     HOXC11-mediated regulation of mitochondrial function modulates chemoresistance in colorectal cancer.
     BMC Cancer. 2024;24:921.
     PubMed     Abstract available
     
     
     
296. WU Y, Tong Y, Zhang H, Li Y, et al
     A novel dual-target Septin9 methylation assay for improved detection of early-stage colorectal cancer and high-grade intraepithelial neoplasia.
     BMC Cancer. 2024;24:916.
     PubMed     Abstract available
     
     
     
297. SUN Q, Long L
     Diagnostic performances of methylated septin9 gene, CEA, CA19-9 and platelet-to-lymphocyte ratio in colorectal cancer.
     BMC Cancer. 2024;24:906.
     PubMed     Abstract available
     
     
     
298. ALVAREZ JA, Shi Q, Dasari A, Garcia-Aguilar J, et al
     Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rec
     BMC Cancer. 2024;24:901.
     PubMed     Abstract available
     
     
     
299. ZHAN Y, Cheng X, Mei P, Tan S, et al
     Safety of first-line systemic therapy in patients with metastatic colorectal cancer: a network meta-analysis of randomized controlled trials.
     BMC Cancer. 2024;24:893.
     PubMed     Abstract available
     
     
     
300. KARTHAUS M, Heinemann V, Riera-Knorrenschild J, Kretzschmar A, et al
     Subgroup analyses from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial.
     BMC Cancer. 2024;24:887.
     PubMed     Abstract available
     
     
     
301. SUE-CHUE-LAM C, Brezden-Masley C, Sutradhar R, Yu AYX, et al
     Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospective cohort study.
     BMC Cancer. 2024;24:878.
     PubMed     Abstract available
     
     
     
302. TANG C, He F, Yang F, Chen D, et al
     Development and validation of a nomogram for preoperatively predicting permanent stoma after rectal cancer surgery with ileostomy: a retrospective cohort study.
     BMC Cancer. 2024;24:874.
     PubMed     Abstract available
     
     
     
303. YANG J, Ding X, Fang Z, Wu S, et al
     Association of CD8(+)TILs co-expressing granzyme A and interferon-gamma with colon cancer cells in the tumor microenvironment.
     BMC Cancer. 2024;24:869.
     PubMed     Abstract available
     
     
     
304. LI A, Gao H, Wu H, Xie Y, et al
     Genetic association and functional implications of TLR4 rs1927914 polymorphism on colon cancer risk.
     BMC Cancer. 2024;24:858.
     PubMed     Abstract available
     
     
     
305. MIAO X, Wang F, Yunus MA, Ismail IS, et al
     Long noncoding RNA KCNMA1-AS2 regulates the function of colorectal cancer cells and sponges miR-1227-5p.
     BMC Cancer. 2024;24:857.
     PubMed     Abstract available
     
     
     
306. BINIAZ M, Moradi A, Basit MG, Pashaki AS, et al
     Combination of neoadjuvant and adjuvant chemotherapy with FOLFOX compared with adjuvant chemotherapy in management of locally advanced rectal cancers: a randomized trial of a promising therapeutic approach.
     BMC Cancer. 2024;24:863.
     PubMed     Abstract available
     
     
     
307. LI X, Wu X, Chen C, Chao H, et al
     A randomized controlled trial of a self-led, virtual reality-based cognitive behavioral therapy on sick role adaptation in colorectal cancer patients: study protocol.
     BMC Cancer. 2024;24:847.
     PubMed     Abstract available
     
     
     
308. LI Y, Hu G, Zhang J, Qiu W, et al
     Nomogram for predicting the probability of rectal anastomotic re-leakage after stoma closure: a retrospective study.
     BMC Cancer. 2024;24:834.
     PubMed     Abstract available
     
     
     
309. MATBOLI M, Hossam N, Farag D, Hassan M, et al
     miRNAs: possible regulators of toll like receptors and inflammatory tumor microenvironment in colorectal cancer.
     BMC Cancer. 2024;24:824.
     PubMed     Abstract available
     
     
     
310. AYNALEM ZB, Adal AB, Ayele TF, Bayeh GM, et al
     Mortality rate and predictors of colorectal cancer patients in Ethiopia: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:821.
     PubMed     Abstract available
     
     
     
311. TALBOT A, Jebb SA, Foster C, Realpe AX, et al
     Participants' perspectives of being recruited into a randomised trial of a weight loss intervention before colorectal cancer surgery: a qualitative interview study.
     BMC Cancer. 2024;24:802.
     PubMed     Abstract available
     
     
     June 2024
312. LIU X, Wang Y, Wang W, Dong H, et al
     The association between systemic immune-inflammation index and cardiotoxicity related to 5-Fluorouracil in colorectal cancer.
     BMC Cancer. 2024;24:782.
     PubMed     Abstract available
     
     
     
313. XU J, Pan L, Wu D, Yao L, et al
     Comparison of the diagnostic value of various microRNAs in blood for colorectal cancer: a systematic review and network meta-analysis.
     BMC Cancer. 2024;24:770.
     PubMed     Abstract available
     
     
     
314. XU M, Chen Y, Li P, Ye Q, et al
     Antibiotic use during radical surgery in stage I-III colorectal cancer: correlation with outcomes?
     BMC Cancer. 2024;24:769.
     PubMed     Abstract available
     
     
     
315. LI A, Li Q, Wang C, Bao X, et al
     Constructing a prognostic model for colon cancer: insights from immunity-related genes.
     BMC Cancer. 2024;24:758.
     PubMed     Abstract available
     
     
     
316. HUANG R, Jin X, Jiang Z, Wang Y, et al
     Genetically evaluating the causal role of peripheral immune cells in colorectal cancer: a two-sample Mendelian randomization study.
     BMC Cancer. 2024;24:753.
     PubMed     Abstract available
     
     
     
317. TAKAHASHI M, Sakamoto K, Kogure Y, Nojiri S, et al
     Use of 3D-CT-derived psoas major muscle volume in defining sarcopenia in colorectal cancer.
     BMC Cancer. 2024;24:741.
     PubMed     Abstract available
     
     
     
318. LIU Q, Wang H, Chen Q, Luo R, et al
     Nomogram incorporating preoperative pan-immune-inflammation value and monocyte to high-density lipoprotein ratio for survival prediction in patients with colorectal cancer: a retrospective study.
     BMC Cancer. 2024;24:740.
     PubMed     Abstract available
     
     
     
319. HOU C, Liu J, Liu J, Yao D, et al
     METTL3-induced circ_0008345 contributes to the progression of colorectal cancer via the microRNA-182-5p/CYP1A2 pathway.
     BMC Cancer. 2024;24:728.
     PubMed     Abstract available
     
     
     
320. NIU Y, Wen L, Yang Y, Zhang Y, et al
     Diagnostic performance of Node Reporting and Data System (Node-RADS) for assessing mesorectal lymph node in rectal cancer by CT.
     BMC Cancer. 2024;24:716.
     PubMed     Abstract available
     
     
     
321. ZHAN ZQ, Huang ZM, Lan QW, Luo YH, et al
     Integrated multi-omics analyses revealed the association between rheumatoid arthritis and colorectal cancer: MYO9A as a shared gene signature and an immune-related therapeutic target.
     BMC Cancer. 2024;24:714.
     PubMed     Abstract available
     
     
     
322. BIYU H, Mengshan L, Yuxin H, Ming Z, et al
     A miRNA-disease association prediction model based on tree-path global feature extraction and fully connected artificial neural network with multi-head self-attention mechanism.
     BMC Cancer. 2024;24:683.
     PubMed     Abstract available
     
     
     
323. YE J, Ying J, Chen H, Wu Z, et al
     PPIH acts as a potential predictive biomarker for patients with common solid tumors.
     BMC Cancer. 2024;24:681.
     PubMed     Abstract available
     
     
     
324. AQUINO DE MORAES FC, Dantas Leite Pessoa FD, Duarte de Castro Ribeiro CH, Rodrigues Fernandes M, et al
     Trifluridine-tipiracil plus bevacizumab versus trifluridine-tipiracil monotherapy for chemorefractory metastatic colorectal cancer: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:674.
     PubMed     Abstract available
     
     
     
325. LI KZ, Liao XM, Li SQ, Wei HT, et al
     Identification and diagnostic potential of hsa_circ_101303 in colorectal cancer: unraveling a regulatory network.
     BMC Cancer. 2024;24:671.
     PubMed     Abstract available
     
     
     May 2024
326. YOSHIMOTO T, Nishi M, Okikawa S, Yoshikawa K, et al
     Blue light irradiation inhibits the M2 polarization of the cancer-associated macrophages in colon cancer.
     BMC Cancer. 2024;24:664.
     PubMed     Abstract available
     
     
     
327. WANG X, Guan X, Tong Y, Liang Y, et al
     UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
     BMC Cancer. 2024;24:644.
     PubMed     Abstract available
     
     
     
328. SHI X, Zhao X, Xue J, Jia E, et al
     Extracellular vesicle biomarkers in circulation for colorectal cancer detection: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:623.
     PubMed     Abstract available
     
     
     
329. WANG JY, Zhang XP, Zhou HK, Cai HX, et al
     The selective sponging of miRNAs by OIP5-AS1 regulates metabolic reprogramming of pyruvate in adenoma-carcinoma transition of human colorectal cancer.
     BMC Cancer. 2024;24:611.
     PubMed     Abstract available
     
     
     
330. ELSHAMI M, Dwikat MF, Al-Slaibi I, Alser M, et al
     Understanding the interplay of colorectal cancer awareness and attitudes among Palestinians: a national cross-sectional study.
     BMC Cancer. 2024;24:590.
     PubMed     Abstract available
     
     
     
331. SLANINOVA V, Heron-Milhavet L, Robin M, Jeanson L, et al
     The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells.
     BMC Cancer. 2024;24:587.
     PubMed     Abstract available
     
     
     
332. ZHANG H, Li X, Sun W, Qin H, et al
     PTEN and P-4E-BP1 might be associated with postoperative recurrence of rectal cancer patients undergoing concurrent radiochemotherapy.
     BMC Cancer. 2024;24:582.
     PubMed     Abstract available
     
     
     
333. CAI J, Yang Y, Zhang L, Fang Y, et al
     Investigation of ENO2 as a promising novel marker for the progression of colorectal cancer with microsatellite instability-high.
     BMC Cancer. 2024;24:573.
     PubMed     Abstract available
     
     
     
334. SUN L, Wang J, Li Y, Kang Y, et al
     Correlation of gasdermin B staining patterns with prognosis, progression, and immune response in colorectal cancer.
     BMC Cancer. 2024;24:567.
     PubMed     Abstract available
     
     
     April 2024
335. CUNNINGHAM R, Stanley J, Imlach F, Haitana T, et al
     Cancer diagnosis after emergency presentations in people with mental health and substance use conditions: a national cohort study.
     BMC Cancer. 2024;24:546.
     PubMed     Abstract available
     
     
     
336. RAO L, Xu P, Zhang G, Zu R, et al
     Prognostic value of creatine kinase (CK)-MB to total-CK ratio in colorectal cancer patients after curative resection.
     BMC Cancer. 2024;24:543.
     PubMed     Abstract available
     
     
     
337. WU Y, Chen C, Hua X, Zhao C, et al
     Association of the TRIM family protein with survival outcomes and clinicopathological features in colorectal cancer: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:537.
     PubMed     Abstract available
     
     
     
338. ALSADHAN N, Alhurishi SA, Pujades-Rodriguez M, Shuweihdi F, et al
     Demographic and clinical characteristics associated with advanced stage colorectal cancer: a registry-based cohort study in Saudi Arabia.
     BMC Cancer. 2024;24:533.
     PubMed     Abstract available
     
     
     
339. HU S, Xiao Q, Gao R, Qin J, et al
     Identification of BGN positive fibroblasts as a driving factor for colorectal cancer and development of its related prognostic model combined with machine learning.
     BMC Cancer. 2024;24:516.
     PubMed     Abstract available
     
     
     
340. LIU H, Xu H, Liu Y, Zhao Y, et al
     Comparative characteristics of early-onset vs. late-onset advanced colorectal cancer: a nationwide study in China.
     BMC Cancer. 2024;24:503.
     PubMed     Abstract available
     
     
     
341. XU T, Feng L, Zhang W, Li H, et al
     The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II study.
     BMC Cancer. 2024;24:501.
     PubMed     Abstract available
     
     
     
342. SOOMRO MY, Khan SR, Muhammad H, Ahmad S, et al
     Exploring treatment outcomes in Stage II-III rectal cancer patients undergoing neoadjuvant therapy at a tertiary care center in Pakistan: a comprehensive analysis of pathological outcomes.
     BMC Cancer. 2024;24:479.
     PubMed     Abstract available
     
     
     
343. LI Y, Chen Z, Tian S, Han X, et al
     Stereotactic ablative brachytherapy versus percutaneous microwave ablation as salvage treatments for lung oligometastasis from colorectal cancer.
     BMC Cancer. 2024;24:481.
     PubMed     Abstract available
     
     
     
344. WADDELL O, Pearson J, McCombie A, Marshall H, et al
     The incidence of early onset colorectal cancer in Aotearoa New Zealand: 2000-2020.
     BMC Cancer. 2024;24:456.
     PubMed     Abstract available
     
     
     
345. ELEZ E, Cubillo A, Alfonso PG, Middleton MR, et al
     Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study.
     BMC Cancer. 2024;24:446.
     PubMed     Abstract available
     
     
     
346. HUANG Y, Chen D, Bai Y, Zhang Y, et al
     ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
     BMC Cancer. 2024;24:452.
     PubMed     Abstract available
     
     
     
347. CHEN H, Wang C, Chen Z, Huang T, et al
     The depth of perineural invasion is an independent prognostic factor for stage II colorectal cancer.
     BMC Cancer. 2024;24:433.
     PubMed     Abstract available
     
     
     
348. TIAN Y, Wang Y, Wen N, Wang S, et al
     Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:426.
     PubMed     Abstract available
     
     
     
349. XIAO Y, Wen X, Ying Y, Zhang X, et al
     Correlation between spleen density and prognostic outcomes in patients with colorectal cancer after curative resection.
     BMC Cancer. 2024;24:425.
     PubMed     Abstract available
     
     
     
350. GHOFRANI-SHAHPAR M, Pakravan K, Razmara E, Amooie F, et al
     Cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production.
     BMC Cancer. 2024;24:400.
     PubMed     Abstract available
     
     
     March 2024
351. LEE KH, Yang IJ, Ha GW, Lee J, et al
     mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial.
     BMC Cancer. 2024;24:397.
     PubMed     Abstract available
     
     
     
352. MAHDI-ESFERIZI R, Shiasi Z, Heidari R, Najafi A, et al
     Single-cell transcriptional signature-based drug repurposing and in vitro evaluation in colorectal cancer.
     BMC Cancer. 2024;24:371.
     PubMed     Abstract available
     
     
     
353. STORM KS, Astrom LM, Sibolt P, Behrens CP, et al
     ROAR-A: re-optimization based Online Adaptive Radiotherapy of anal cancer, a prospective phase II trial protocol.
     BMC Cancer. 2024;24:374.
     PubMed     Abstract available
     
     
     
354. DING H, Lin J, Xu Z, Wang HHX, et al
     The association between organised colorectal cancer screening strategies and reduction of its related mortality: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:365.
     PubMed     Abstract available
     
     
     
355. LIN T, Zhang S, Tang Y, Xiao M, et al
     ART1 knockdown decreases the IL-6-induced proliferation of colorectal cancer cells.
     BMC Cancer. 2024;24:354.
     PubMed     Abstract available
     
     
     
356. MATHUR S, Srivastava P, Srivastava A, Rai NK, et al
     Regulation of metastatic potential by drug repurposing and mitochondrial targeting in colorectal cancer cells.
     BMC Cancer. 2024;24:323.
     PubMed     Abstract available
     
     
     
357. XIA S, Li Q, Zhu HT, Zhang XY, et al
     Fully semantic segmentation for rectal cancer based on post-nCRT MRl modality and deep learning framework.
     BMC Cancer. 2024;24:315.
     PubMed     Abstract available
     
     
     
358. DUAN J, Zhu L, Shi Y, Wang W, et al
     Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.
     BMC Cancer. 2024;24:302.
     PubMed     Abstract available
     
     
     
359. HUANG JX, Zhang X, Tang M, Zhang Q, et al
     Comprehensive evaluation of serum hepatic proteins in predicting prognosis among cancer patients with cachexia: an observational cohort study.
     BMC Cancer. 2024;24:293.
     PubMed     Abstract available
     
     
     February 2024
360. SONG M, Zhou X, Hou R, Sigdel M, et al
     CT-guided radioactive (125)I seeds brachytherapy for lung oligometastases from colorectal cancer: initial results.
     BMC Cancer. 2024;24:265.
     PubMed     Abstract available
     
     
     
361. LIU Y, Hu X, Huang Y, Yin X, et al
     Does transanal drainage tubes placement have an impact on the incidence of anastomotic leakage after rectal cancer surgery? a systematic review and meta-analysis.
     BMC Cancer. 2024;24:263.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum